TY - JOUR
T1 - What Matters When Providing Conversational Recast Treatment? A Multilevel Modeling Analysis
AU - Choi-Tucci, Alexander
AU - Sachs, Alyssa
AU - Burton, Rebecca
AU - Vance, Rebecca
AU - Plante, Elena
N1 - Publisher Copyright:
© 2025 American Speech-Language-Hearing Association.
PY - 2025/3
Y1 - 2025/3
N2 - Purpose: Conversational recasting treatment is generally effective. However, different versions of this treatment and different targets may yield different outcomes for children. Here, we directly compare multiple variations of conversational recasting to determine how modifications to delivery and target impact treatment outcomes. Method: Using Bayesian hierarchical linear mixed modeling, we compared outcome data from 141 children with developmental language disorder (DLD) across 10 versions of recast treatment compared with enhanced conversational recast treatment (a version that incorporates linguistic variability and attentional cues). We also compared data from a subset of 132 children treated for one of five morphological targets to determine the relative difficulty of learning each target. Results: Results suggest that seven of the 10 treatment conditions resulted in an average decrease in generalization probe performance relative to enhanced conversational recasting alone. These conditions resulted in probe performance that was between 47% and 84% worse than performance of children who received enhanced conversational recasting with no variations. The remaining three conditions were no better or worse than enhanced conversational recasting. One treatment target was easier to remediate, while the other four were no easier or harder to acquire through treatment. Conclusions: These results suggest that different variations of conversational recasting facilitate or diminish learning by children with DLD and that clinicians’ attention to the form and structure of treatment delivery is necessary to implement best practice for this treatment method. In contrast, clinicians may have more flexibility when selecting targets.
AB - Purpose: Conversational recasting treatment is generally effective. However, different versions of this treatment and different targets may yield different outcomes for children. Here, we directly compare multiple variations of conversational recasting to determine how modifications to delivery and target impact treatment outcomes. Method: Using Bayesian hierarchical linear mixed modeling, we compared outcome data from 141 children with developmental language disorder (DLD) across 10 versions of recast treatment compared with enhanced conversational recast treatment (a version that incorporates linguistic variability and attentional cues). We also compared data from a subset of 132 children treated for one of five morphological targets to determine the relative difficulty of learning each target. Results: Results suggest that seven of the 10 treatment conditions resulted in an average decrease in generalization probe performance relative to enhanced conversational recasting alone. These conditions resulted in probe performance that was between 47% and 84% worse than performance of children who received enhanced conversational recasting with no variations. The remaining three conditions were no better or worse than enhanced conversational recasting. One treatment target was easier to remediate, while the other four were no easier or harder to acquire through treatment. Conclusions: These results suggest that different variations of conversational recasting facilitate or diminish learning by children with DLD and that clinicians’ attention to the form and structure of treatment delivery is necessary to implement best practice for this treatment method. In contrast, clinicians may have more flexibility when selecting targets.
UR - http://www.scopus.com/inward/record.url?scp=105001215079&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=105001215079&partnerID=8YFLogxK
U2 - 10.1044/2024_AJSLP-24-00138
DO - 10.1044/2024_AJSLP-24-00138
M3 - Article
C2 - 39761110
AN - SCOPUS:105001215079
SN - 1058-0360
VL - 34
SP - 469
EP - 486
JO - American journal of speech-language pathology
JF - American journal of speech-language pathology
IS - 2
ER -